| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 16052-09-8 | 2,6-Pyridinediamine,4-(2-methoxyethoxy)-; Pyridine,2,6-diamino-4-(2-methoxyethoxy)- (8CI); NSC 409378 |  | C8H13N3O2 | 詳情 | 供應(yīng)商 | |
| 103061-91-2 | 2,4(1H,3H)-Pyrimidinedione,1-[6-[(6-chloro-2-methoxy-9-acridinyl)amino]hexyl]-5-methyl- |  | C25H27ClN4O3 | 詳情 | 供應(yīng)商 | |
| 111711-55-8 | 2-Pyrrolidinone,1-[(3,4-dichlorophenyl)sulfonyl]-5-ethoxy- |  | C12H13Cl2NO4S | 詳情 | 供應(yīng)商 | |
| 64039-31-2 | 2-Hexadecyl-1,3-dimethyl-2-thiopseudourea hydrochloride |  | C19H41ClN2S | 詳情 | 供應(yīng)商 | |
| 302-34-1 | 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(2-cyclopenten-1-yl)-5-(2-propen-1-yl)-, sodium salt (1:1); 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(2-cyclopenten-1-yl)-5-(2-propenyl)-, monosodium salt (9CI); Barbituric acid,5-allyl-5-(2-cyclopenten-1-yl)-, sodium deriv. (6CI); Barbituric acid,5-allyl-5-(2-cyclopenten-1-yl)-, sodium salt (8CI); 5-Allyl-5-(2-cyclopenten-1-yl)barbituric acid sodium salt; Cyclopal sodium; Cyclopentobarbitalsodium; Sodium cyclopal; Sodium cyclopentobarbital |  | C12H13N2NaO3 | 詳情 | 供應(yīng)商 | |
| 134616-45-8 | 2H-1,4-Benzothiazine-2-acetamide,3,4-dihydro-N-(2-methylphenyl)-3-oxo- |  | C17H16N2O2S | 詳情 | 供應(yīng)商 | |
| 5307-94-8 | 2,4,11,13-Tetraoxa-3,12-diphosphadispiro[5.2.5.2]hexadecane,3,12-diethoxy-; Phosphorousacid, ethyl ester, cyclic 1,1:4,4-diester with 1,1,4,4-cyclohexanetetramethanol(8CI); Phosphorous acid, ethyl ester, cyclic diester with1,1,4,4-cyclohexanetetramethanol (7CI); 2,4,11,13-Tetraoxa-3,12-diphosphadispiro[5.2.5.2]hexadecane, 3,6-diethoxy- |  | C14H26O6P2 | 詳情 | 供應(yīng)商 | |
| 16403-07-9 | 2-Pentenoic acid,2-ethyl-, (2E)-; 2-Pentenoicacid, 2-ethyl-, (E)- (8CI); NSC 244945 |  | C7H12O2 | 詳情 | 供應(yīng)商 | |
| 14656-26-9 | 2-Propenoic acid,2-(diethoxyphosphinyl)-3-(3,4-dimethoxyphenyl)-, ethyl ester; Cinnamicacid, 3,4-dimethoxy-a-phosphono-, triethyl ester (8CI); NSC 102265 |  | C17H25O7P | 詳情 | 供應(yīng)商 | |
| 53933-35-0 | 2-Pyrrolidinecarboxamide,1-(2,2-dimethyl-1-oxopropyl)-N-methyl-, (S)- (9CI); pivaloyl-proline N-methylamide |  | C11H20N2O2 | 詳情 | 供應(yīng)商 | |
| 857767-34-1 | 2,4-Imidazolidinedione,5-(ethoxymethyl)-; Hydantoin,5-(ethoxymethyl)- (5CI) |  | C6H10N2O3 | 詳情 | 供應(yīng)商 | |
| 857766-66-6 | 2,4-Imidazolidinedione,5-(chloromethyl)-; Hydantoin,5-(chloromethyl)- (5CI) |  | C4H5ClN2O2 | 詳情 | 供應(yīng)商 | |
| 5469-78-3 | 2-Furancarboxylic acid,5-nitro-, hydrazide; 2-Furoicacid, 5-nitro-, hydrazide (6CI,7CI); 5-Nitro-2-furancarbonylhydrazine; 5-Nitro-2-furohydrazide; 5-Nitro-2-furoic acid hydrazide; 5-Nitrofuran-2-carboxylic acid hydrazide; NSC 124507; NSC 25251; NSC 38565; NSC53267 |  | C5H5N3O4 | 詳情 | 供應(yīng)商 | |
| 64567-41-5 | 2(1H)-Pyrimidinone,4-amino-1-(tetrahydro-5-oxo-2-furanyl)-; 4-amino-1-(5-oxooxolan-2-yl)pyrimidin-2-one |  | C8H9N3O3 | 詳情 | 供應(yīng)商 | |
| 857272-02-7 | 2H-1,4-Benzoxazin-3(4H)-one,6-(chloromethyl)-4-(3-methoxypropyl)-; 6-Chloromethyl-4-(3-methoxypropyl)-4H-benzo[1,4]oxazin-3-one |  | C13H16ClNO3 | 詳情 | 供應(yīng)商 | |
| 857265-74-8 | 2-Pyrimidinamine,5-ethynyl-; 2-Amino-5-ethynylpyrimidine |  | C6H5N3 | 詳情 | 供應(yīng)商 | |
| 114127-17-2 | 2,4-Heptadienoic acid,7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxo-, (2E,4E)-; 2,4-Heptadienoicacid, 7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxo-, (E,E)- (9CI); 2,4-Heptadienoic acid, 7-[4-(dimethylamino)phenyl]-4,6-dimethyl-7-oxo-, (E,E)-(?à)- |  | C17H21NO3 | 詳情 | 供應(yīng)商 | |
| 17359-53-4 | 2H-1,4-Benzoxazin-3(4H)-one,2-hydroxy-7-methoxy-; 2-Hydroxy-7-methoxy-1,4-(2H)-benzoxazin-3-one; 2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one; 2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3-one; HMBOA |  | C9H9NO4 | 詳情 | 供應(yīng)商 | |
| 33340-36-2 | 2-Naphthalenesulfonicacid, 6-hydroxy-5-[2-(methylphenyl)diazenyl]-, sodium salt (1:1); 2-Naphthalenesulfonicacid, 6-hydroxy-5-[(methylphenyl)azo]-, monosodium salt (9CI); C.I. Acid Orange16 (7CI); C.I. 16011 |  | C17H13N2NaO4S | 詳情 | 供應(yīng)商 | |
| 856965-66-7 | 2(1H)-Pyridinone,4,5-dichloro-; 2-Pyridinol,4,5-dichloro- (5CI) |  | C5H3Cl2NO | 詳情 | 供應(yīng)商 | |